重症监护治疗病房分离菌耐药性检测分析

    A surveillance study on bacterial resistance in the Intensive Care Unit

    • 摘要: 目的:了解重症监护治疗病房(ICU)分离菌对抗菌药物的耐药状况。方法:取2006年11月至2009年1月ICU患者标本做细菌培养,检出病原菌,用K-B纸片扩散法测定药敏,以表型确认法检测超广谱β内酰胺酶菌株。结果:共收集致病菌33株,其中革兰阴性杆菌29株(87.9%),革兰阳性球菌4株(12.1%)。以假单胞菌、大肠埃希菌为多。头孢哌酮/舒巴坦对革兰阴性杆菌抗菌作用最强,而万古霉素对革兰阳性球菌抗菌作用最强。结论:ICU患者感染以革兰阴性杆菌为主。头孢哌酮/舒巴坦作用最强。加强病原菌及药敏监测,以指导临床合理使用抗菌药物。

       

      Abstract: Objective:To study the antimicrobial resistance of clinical isolates from Intensive Care Unit(ICU).Methods:The specimens of the patients who were in Bengbu Second People's Hospital from Nov.2006 to Jun.2009 were cultured to detect the pathogens.K-B agar diffusion method was used to judge drug sensitivity.Phenotypic confirmatory test was used to detect ESBLs.Results:A total of 33 clinical isolates,including 29 strains (87.9%)of Gram-positive bacilli and 4 strains (12.1%)of Gram-negative bacilli,were collected.Pseudomonas and E.coli was the main microorganism.The most active agent against Gram-negative organisms was Cefoperazone/sulbactam and Vancomycin was the most effective on Gram-positive cocci.Conclusions:The Gram-nagative bacilli was the major pathogen isolated from ICU patients; cefoperazone/sulbactam was the most effective.Pathogens and drug sensitivity monitoring should be enhanced to give guidance for rational use of antibiotics.

       

    /

    返回文章
    返回